These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3166416)

  • 1. Factor X deficiency during treatment of relapsed acute myeloid leukaemia with amsacrine.
    Carter C; Winfield DA
    Clin Lab Haematol; 1988; 10(2):225-8. PubMed ID: 3166416
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of Christmas disease and Stuart-Prower deficiency with a prothrombin-complex concentrate (factors II, VII, IX, X).
    Tullis JL; Melin M
    Bibl Haematol; 1968; 29():1134-9. PubMed ID: 5700309
    [No Abstract]   [Full Text] [Related]  

  • 3. Prothrombal: a new concentrate of human prothrombin complex for clinical use.
    Bruning PF; Loeliger EA
    Br J Haematol; 1971 Oct; 21(4):377-98. PubMed ID: 5001176
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical use of human prothrombin complexes.
    Tullis JL; Melin M; Jurigian P
    N Engl J Med; 1965 Sep; 273(13):667-74. PubMed ID: 5827030
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic approaches to factor X deficiency with emphasis on the use of a new clotting-factor concentrate (Konyne).
    O'Leary DS; Ruymann FB; Conrad ME
    J Lab Clin Med; 1971 Jan; 77(1):23-32. PubMed ID: 5540427
    [No Abstract]   [Full Text] [Related]  

  • 6. The therapeutic use of fraction P.P.S.B.
    Soulier JP; Josso F; Steinbuch M; Cosson A
    Bibl Haematol; 1968; 29():1127-33. PubMed ID: 5700308
    [No Abstract]   [Full Text] [Related]  

  • 7. Factor X survival and therapeutic factor X levels in the abnormal factor X (factor X FRIULI) COAGULATION DISORDER.
    Girolami A; Molaro G; De Marco L
    Acta Haematol; 1974; 52(4):223-31. PubMed ID: 4217528
    [No Abstract]   [Full Text] [Related]  

  • 8. Amsacrine is safe and effective therapy for patients with myocardial dysfunction and acute leukemia.
    Arlin ZA; Feldman EJ; Mittelman A; Ahmed T; Puccio C; Chun HG; Cook P; Baskind P; Marboe C; Mehta R
    Cancer; 1991 Sep; 68(6):1198-200. PubMed ID: 1873770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resolution of factor X deficiency in primary amyloidosis following splenectomy.
    Rosenstein ED; Itzkowitz SH; Penziner AS; Cohen JI; Mornaghi RA
    Arch Intern Med; 1983 Mar; 143(3):597-9. PubMed ID: 6830397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose cytosine arabinoside and amsacrine or mitoxantrone in relapsed and refractory acute myeloid leukaemia: a prospective randomized study.
    Martiat P; Ghilain JM; Ferrant A; Doyen C; Delannoy A; Chatelain C; Bosly A; Michaux JL; Sokal G
    Eur J Haematol; 1990 Sep; 45(3):164-7. PubMed ID: 2226729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy of refractory or recurrent childhood acute myeloid leukemia using amsacrine and etoposide with or without azacitidine: a Pediatric Oncology Group randomized phase II study.
    Steuber CP; Krischer J; Holbrook T; Camitta B; Land V; Sexauer C; Mahoney D; Weinstein H
    J Clin Oncol; 1996 May; 14(5):1521-5. PubMed ID: 8622066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letter: Prothrombin complex to treat factor VIII inhibition.
    Tishkoff GH
    N Engl J Med; 1975 Apr; 292(14):754-5. PubMed ID: 1113790
    [No Abstract]   [Full Text] [Related]  

  • 13. Amsacrine: a review.
    Cassileth PA; Gale RP
    Leuk Res; 1986; 10(11):1257-65. PubMed ID: 3540460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [ACQUIRED FACTOR X DEFICIENCY IN A PATIENT WITH PRIMARY AMYLOIDOSIS. INJECTION OF A B.S.C. FRACTION].
    MENACHE D; BOIVIN P
    Bibl Haematol; 1964; 19():185-91. PubMed ID: 14266996
    [No Abstract]   [Full Text] [Related]  

  • 15. [Is the administration of prothrombin concentrate in heart infarct always absolutely contraindicated?].
    Schricker KT; Haasis R
    Med Klin; 1972 Jun; 67(24):841-5. PubMed ID: 5070409
    [No Abstract]   [Full Text] [Related]  

  • 16. Human prothrombin complex.
    N Engl J Med; 1965 Sep; 273(13):715-6. PubMed ID: 5827038
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase II trial of amsacrine plus intermediate-dose Ara-C (IDAC) with or without etoposide as salvage therapy for refractory or relapsed acute leukemia.
    Sung WJ; Kim DH; Sohn SK; Kim JG; Baek JH; Jeon SB; Moon JH; Ahn BM; Lee KB
    Jpn J Clin Oncol; 2005 Oct; 35(10):612-6. PubMed ID: 16172175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prothrombin complex concentrate (Beriplex P/N).
    Scott LJ
    Drugs; 2009 Oct; 69(14):1977-84. PubMed ID: 19747012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical care of patients with hereditary disorders of blood coagulation.
    Shulman NR
    Mod Treat; 1968 Jan; 5(1):61-83. PubMed ID: 4870180
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of amyloidosis associated factor X deficiency.
    Spero JA; Lewis JH; Hasiba U; Ellis LD
    Thromb Haemost; 1976 Apr; 35(2):377-81. PubMed ID: 989637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.